Fig. 2From: Immune response induced by oral administration with a Saccharomyces cerevisiae-based SARS-CoV-2 vaccine in miceHumoral and mucosal immune responses elicited by EBY100/pYD1-RBD. a RBD-specific serum IgG titers (n = 10 mice/group). b Secretory IgA in the feces (n = 10 mice/group). The data shown are the means ± SDs of three technical replicates per measurement, and the asterisks indicate significant differences compared with the PBS- and EBY100/pYD1-vaccinated controls. *p < 0.05, **p < 0.01Back to article page